Oxidative stress, resulting either from excess generation or reduced s
cavenging of free radicals, has been proposed to play a role in damagi
ng striatal neurons in Parkinson's disease. Since metallothionein is a
ble to regulate the intracellular redox potential, we have undertaken
a group of experiments to learn whether or not 6-hydroxydopamine, whic
h generates free radicals and is toxic to dopaminergic neurons, could
alter the levels of zinc and metallothionein in the brain. The lesioni
ng of the rat striatum with 6-hydroxydopamine (8.0 mu g in 4 mu I 0.02
% ascorbic acid) resulted in a reduction in the levels of zinc and met
allothionein in the striatum but nor other brain regions tested. Howev
er, the intracerebroventricular administration of 6-hydroxydopamine, i
n a dosage regimen that does not lesion catecholaminergic pathways bur
causes oxidative stress, enhanced dramatically the level of metalloth
ionein I mRNA in some brain areas such as hippocampus, arcuate nucleus
, choroid plexus, and granular layer of cerebellum, but not in the cau
date putamen. The results of these studies are interpreted to suggest
that zinc or metallothionein are altered in conditions where oxidative
stress has ta ken place. Moreover, it is proposed that areas of brain
, such as striatum containing high concentrations of iron, but low lev
els of inducible metallothionein are particularly vulnerable to oxidat
ive stress. (C) 1996 Intox Press, Inc.